Table 3

The per cent of patients being ignored in each site between WISENSE and control group

Ignored sitesNumber (%)% Risk difference (95% CI)P value
WISENSE (n=153)Control (n=150)
Oesophagus0 (0.00)0 (0.00)NANA
Squamocolumnar junction0 (0.00)2 (1.33)−1.33% (−4.74 to 1.14)0.24
Antrum (G)0 (0.00)5 (3.33)−3.33% (−7.57 to −0.84)0.03
Antrum (P)4 (2.61)15 (10.00)−7.39% (−13.56 to −2.10)0.008
Antrum (A)4 (2.61)10 (6.67)−4.05% (−9.56 to 0.77)0.10
Antrum (L)6 (3.92)14 (9.33)−5.41% (−11.63 to 0.20)0.06
Duodenal bulb1 (0.65)6 (4.00)−3.35% (−7.89 to 0.05)0.06
Duodenal descending0 (0.00)9 (6.00)−6.00% (−11.01 to −3.19)0.002
Lower body (G)4 (2.61)26 (17.33)−14.72% (−21.89 to −8.48)<0.001
Lower body (P)20 (13.07)44 (29.33)−16.26% (−25.36 to −7.17)<0.001
Lower body (A)11 (7.19)28 (18.67)−11.48% (−18.29 to −4.06)0.003
Lower body (L)8 (5.23)45 (30.00)−24.77% (−33.13 to −16.76)<0.001
Middle-upper body (F, G)4 (2.61)8 (5.33)−2.72% (−7.90 to 1.91)0.244
Middle-upper body (F, P)20 (13.07)52 (34.67)−21.59% (−30.87 to −12.20)<0.001
Middle-upper body (F, A)20 (13.07)64 (42.67)−29.59% (−38.97 to −19.97)<0.001
Middle-upper body (F, L)13 (8.50)84 (56.00)−47.50% (−56.20 to −38.06)<0.001
Fundus (G)4 (2.61)13 (8.67)−6.05% (−11.98 to −0.95)0.02
Fundus (P)13 (8.50)32 (21.33)−12.84% (−21.01 to −4.95)0.002
Fundus (A)22 (14.38)26 (17.33)−2.95% (−11.35 to 5.36)0.49
Fundus (L)29 (18.95)61 (40.67)−21.71% (−31.57 to −11.54)<0.001
Middle-upper body (R, P)10 (6.54)26 (17.33)−10.80% (−18.41 to −3.63)0.003
Middle-upper body (R, A)30 (19.61)61 (40.67)−21.06% (−30.97 to −10.84)<0.001
Middle-upper body (R, L)21 (13.73)36 (24.00)−10.27% (−19.14 to −1.48)0.03
Angulus (P)42 (27.45)96 (64.00)−36.55% (−46.50 to −25.70)<0.001
Angulus (A)19 (12.42)80 (53.33)−40.92% (−50.09 to −31.04)<0.001
Angulus (L)5 (3.27)29 (19.33)−16.07 (−23.51 to −9.42)<0.001